Pivotal Phase III study shows Roche’s Tecentriq helped people with early lung cancer live longer without their disease returning

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing